Study guide
9.5 Comorbidity Screening, Stress Management, and Referral Pathways
AAHFN Certified Heart Failure Nurse CHFN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient History, Risk Factors, and Etiologies
1.1 Heart Failure Etiologies, Risk Factors, and Comorbid Conditions 1.2 Clinical History Taking, Social Determinants of Health, and Device History 1.3 Recognizing Signs and Symptoms of Heart Failure Decompensation
2 Chapter 2: Physical Examination and Hemodynamic Evaluation
2.1 Physical Assessment of Volume and Congestion Status 2.2 Physical Assessment of Perfusion and Low-Output States 2.3 Hemodynamic Profiling and Invasive Hemodynamics
3 Chapter 3: Laboratory Biomarkers and Diagnostic Testing
3.1 Natriuretic Peptides: BNP and NT-proBNP in Clinical Practice 3.2 Essential Laboratory Panels: Renal, Electrolyte, Hepatic, and Iron Evaluation 3.3 Diagnostic Imaging, ECG, and Device Interrogation
4 Chapter 4: Classification, Staging, and Functional Assessment
4.1 ACC/AHA Stages and LVEF Phenotypes 4.2 NYHA Functional Classification, 6-Minute Walk, and Quality-of-Life Measures 4.3 Frailty, Orthostatic Hypotension, and Age-Friendly Care Frameworks
5 Chapter 5: Individualized Care Planning and Shared Decision-Making
5.1 Care Setting Determination and Acuity Stratification 5.2 Formulating Etiology-Directed and Comorbidity-Integrated Goals 5.3 Shared Decision-Making, Patient Preferences, and Social Determinants
6 Chapter 6: GDMT Pharmacotherapy for HFrEF
6.1 The Four Pillars of GDMT: ARNI/ACEi/ARB, Beta-Blockers, MRA, and SGLT2i 6.2 Second-Line and Specialized Pharmacotherapy: Ivabradine, Vericiguat, Digoxin, and Hydralazine-Nitrates 6.3 Medications to Avoid and Drug Safety in Heart Failure
7 Chapter 7: Diuretics, HFpEF, Comorbidity Pharmacotherapy, and Medication Safety
7.1 Diuretic Strategies: Loop Diuretics, Conversions, and Sequential Nephron Blockade 7.2 Management of Heart Failure with Preserved (HFpEF), Mildly Reduced (HFmrEF), and Improved Ejection Fraction (HFimpEF) 7.3 Comorbidity-Directed Pharmacotherapy: Iron Repletion, Anticoagulation, and Immunizations 7.4 Medication Reconciliation, Adjunct Agents, and Drug-Level Monitoring
8 Chapter 8: Device Therapy, Rhythm Management, and Advanced Interventions
8.1 Implantable Devices: ICD and CRT Indications, Titration, and Screening 8.2 Advanced Heart Failure Therapies: Inotropes, Mechanical Circulatory Support (LVAD), and Heart Transplantation 8.3 Ambulatory Hemodynamic Monitoring and Ultrafiltration
9 Chapter 9: Patient Education, Self-Care, Screening, and Referrals
9.1 Self-Care Education and Daily Weight Monitoring 9.2 Dietary Sodium, Fluid Management, and Lifestyle Modifications 9.3 Exercise Prescription, Cardiac Rehabilitation, and Health Literacy 9.4 Individualized Teaching Plans and Learning Methods 9.5 Comorbidity Screening, Stress Management, and Referral Pathways
10 Chapter 10: Therapy Effectiveness, Monitoring, and Care Transitions
10.1 Monitoring and Titration Evaluation: GDMT Tolerance, Lab Trends, and Hemodynamics 10.2 Outpatient and Remote Monitoring Systems 10.3 Post-Acute Care Transitions and Preventing 30-Day Readmissions
11 Chapter 11: Patient Comprehension, Self-Care Adherence, and Palliative Transitions
11.1 Evaluating Patient and Caregiver Education Comprehension 11.2 Identifying and Addressing Adherence Barriers 11.3 Palliative Care, Goals of Care, and End-of-Life Device Management
12 Chapter 12: Professional Standards, Ethics, Quality, and Certification
12.1 Legal Parameters, Ethical Principles, and Patient Advocacy 12.2 Interdisciplinary Collaboration, SBAR Communication, and Care Coordination 12.3 Evidence-Based Guidelines, Quality Improvement, and Addressing Disparities 12.4 Certification, Continuing Education, and Professional Development
9.5 Comorbidity Screening, Stress Management, and Referral Pathways
Key Takeaways Explain This Topic AI
The CHFN outline expects routine screening for chronic pain, cognitive impairment, sleep disorders, depression, suicide risk, anxiety, domestic violence, environmental safety, falls, anemia, thyroid dysfunction, gout, and other common comorbidities.
Any positive answer to PHQ-9 item 9 requires a same-day suicide risk assessment and safety plan, regardless of the total PHQ-9 score.
Gout flares in heart failure are treated with renally dosed colchicine or a short corticosteroid course rather than NSAIDs, and loop and thiazide diuretics raise uric acid.
Genetic counseling is indicated for familial or unexplained cardiomyopathy, such as nonischemic dilated cardiomyopathy with a first-degree relative who died suddenly at a young age.
A referral is complete only when the loop is closed: the patient agrees, access barriers are solved, information is sent, and the nurse confirms the visit happened.
Last updated: September 2026
Why Screening Belongs in the Implementation Domain
Many heart failure admissions are triggered or prolonged by problems outside the heart: untreated depression that stops self-care, sleep apnea that worsens atrial fibrillation, NSAIDs taken for pain or gout, falls from orthostatic hypotension, or an unsafe home. The CHFN outline therefore lists specific conditions to screen for and a long list of referral pathways. The nurse's job is to screen systematically, act on positive results, and make sure referrals actually happen.
Screening Checklist
Condition Why It Matters in Heart Failure Practical Screening Positive Screen: Next Step
Chronic pain Drives NSAID use and inactivity 0-10 pain scale or PEG scale (Pain, Enjoyment, General activity) Non-NSAID plan: acetaminophen, topical agents, physical therapy; pain or palliative referral
Cognitive impairment Undermines medication and weight routines Mini-Cog, MoCA Involve caregiver, simplify regimen, neurology or geriatrics referral
Sleep disorders Sleep apnea worsens hypertension, AF, and remodeling; insomnia may reflect orthopnea or nocturia STOP-Bang, Epworth Sleepiness Scale, questions about orthopnea and nocturia Sleep medicine referral and sleep study; review diuretic timing
Depression Roughly doubles mortality risk and impairs self-care PHQ-2, then PHQ-9 Behavioral health referral; psychotherapy and SSRIs such as sertraline; avoid tricyclics
Suicide risk Hopelessness is common in advanced illness PHQ-9 item 9; structured tools such as the Columbia Suicide Severity Rating Scale Same-day risk assessment, safety plan, 988 Suicide & Crisis Lifeline, means safety
Anxiety Common after ICD shocks and hospitalization; worsens symptoms GAD-2, then GAD-7 Cognitive behavioral therapy, support groups, behavioral health referral
Domestic violence and elder abuse Unsafe homes block self-care and follow-up Private, direct questions or tools such as HITS (Hurt, Insult, Threaten, Scream) Safety planning, social work, National Domestic Violence Hotline (1-800-799-7233), report elder or dependent-adult abuse per state law
Environmental safety Trip hazards, oxygen near smoking or flames, extreme heat without cooling, unsafe medication storage Home safety checklist, home health assessment Home modifications, occupational therapy, utility or cooling assistance
Fall risk Orthostatic hypotension, nocturia, frailty, anticoagulation STEADI three key questions, Timed Up and Go (12 seconds or more is high risk) Physical therapy, medication review, home safety
Anemia Worsens dyspnea, fatigue, and outcomes CBC (hemoglobin below 13 g/dL in men or 12 g/dL in women) Iron studies, bleeding evaluation, IV iron when iron deficient
Thyroid dysfunction Both hyper- and hypothyroidism worsen heart failure; amiodarone causes either TSH Treat thyroid disease; monitor amiodarone users about every 6 months
Gout Diuretics raise uric acid; flares lead to NSAID use Joint symptoms, uric acid Colchicine (renally dosed) or short corticosteroid course for flares; allopurinol for prevention; avoid NSAIDs
Other comorbidities (COPD, atrial fibrillation, kidney disease) Change diagnosis, drug choice, and prognosis Spirometry, pulse and ECG or device data, eGFR and urine albumin Specialist co-management
Managing Stress and Teaching Stress-Reduction Techniques
Stress raises sympathetic tone, disturbs sleep, and makes self-care harder for patients and caregivers. Screening for anxiety and depression is the first step; practical skills are the second. Teach patients and caregivers techniques they can use at home, such as slow paced breathing, progressive muscle relaxation, guided imagery, mindfulness, gentle movement within the exercise prescription, and pacing daily activities. Connect them with support groups and, when symptoms persist, cognitive behavioral therapy. Section 9.2 lists these techniques in more detail.
Referral Pathways
Referral Typical Trigger What It Provides
Heart failure disease management program Recent hospitalization, high readmission risk, GDMT not at target Structured follow-up, titration, education
Social work Financial, housing, transportation, caregiver, or safety problems Resource linkage, counseling, benefits
Home care Homebound, complex regimen, recent discharge Skilled nursing visits, medication and weight checks
Nutritionist or dietitian Sodium or fluid questions, diabetes, CKD diet, cachexia, obesity Individualized nutrition plan
Physical or occupational therapy Falls, frailty, deconditioning, ADL difficulty Strength, balance, energy conservation, equipment
Cardiac specialist Electrophysiologist (ICD, CRT, AF ablation), cardiac surgeon (valve, CABG, LVAD), interventional cardiologist (coronary or structural procedures) Device and procedural evaluation
Non-cardiac specialist Endocrinologist (diabetes, thyroid), psychiatrist, pulmonologist (COPD), nephrologist (advanced CKD), hematologist (anemia, AL amyloidosis) Comorbidity co-management
Cardiac rehabilitation Stable HFrEF meeting coverage criteria Supervised exercise and education
Genetic counseling Familial or unexplained cardiomyopathy, young sudden death in the family, suspected hereditary amyloidosis Genetic testing and family screening
- Remote patient monitoring Frequent decompensation, rural location Daily biometrics or hemodynamic monitoring
- Sleep specialist Positive sleep screen, suspected central or obstructive apnea Sleep study and treatment
Hospice or palliative care High symptom burden, goals-of-care needs, Stage D disease Symptom relief, advance care planning, end-of-life care
Support groups Isolation, anxiety, new diagnosis, caregiver strain Peer support (for example, AHA Support Network, Mended Hearts)
Case management Complex care across settings, insurance coordination Care coordination and utilization support
Prescription assistance programs Unaffordable GDMT Free or reduced-cost medications, foundation grants, Extra Help
Mental health Depression, anxiety, substance use, suicidal thoughts Therapy, medication management, crisis care
Making Referrals Work
Explain the reason in terms of the patient's goals and get agreement.
Solve access barriers first: insurance authorization, transportation, cost, and scheduling.
Use a warm handoff when possible and send the relevant information.
Close the loop: confirm the appointment happened and that recommendations were received, then update the shared care plan.
Clinical Case Scenario: One Visit, Several Positive Screens
A 69-year-old woman with HFpEF and atrial fibrillation returns 2 weeks after discharge. She has knee pain and has been taking naproxen, her PHQ-9 score is 13 with item 9 marked "several days," her STOP-Bang score is 6, and her Timed Up and Go is 15 seconds.
Immediate priority: The nurse completes a same-day suicide risk assessment for the positive item 9, develops a safety plan with her, and arranges urgent behavioral health follow-up.
Medication safety: Naproxen is stopped. The team uses acetaminophen, a topical agent, and physical therapy for knee pain.
Referrals: Sleep medicine for a sleep study, physical therapy for balance and strengthening, and social work for caregiver support. The nurse schedules a call in 1 week to confirm every referral was completed.
CHFN Exam Traps & Clinical Pearls
Exam Trap: A positive PHQ-9 item 9 outranks every other screening result. The correct answer is a same-day suicide risk assessment, not a routine referral.
Clinical Pearl: Ask about pain and gout at every visit. Unrelieved pain is a common reason patients restart NSAIDs.
Exam Trap: Screening for domestic violence must be done privately, without the partner or family present.